                               SEQUENCE LISTING                               

<110> American Cyanamid Company

<120> Assembly of Wild-Type and Chimeric Influenza Virus-Like
      Particles (VLPs)

<130> AM100288PCT

<140>
<141>

<150> PCT/US01/19890
<151> 2001-06-21

<160> 11                            

<170> PatentIn Ver. 2.1

<210> 1
<211> 71
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Chimera of
      portions of Vesicular Stomatitis Virus G protein
      and influenza HA protein

<400> 1
Gly Glu Thr Leu Phe Phe Gly Asp Thr Gly Leu Ser Lys Asn Pro Ile  
  1               5                  10                  15    

Glu Phe Val Glu Gly Trp Phe Ser Ser Trp Lys Ser Lys Ser Gly Tyr  
             20                  25                  30        

Lys Asp Trp Ile Leu Trp Ile Ser Phe Ala Ile Ser Cys Phe Leu Leu  
         35                  40                  45            

Cys Val Val Leu Leu Gly Phe Ile Met Trp Ala Cys Gln Lys Gly Asn  
     50                  55                  60                

Ile Arg Cys Asn Ile Cys Ile                                      
 65                  70    


<210> 2
<211> 42
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Amino acids
      1-42 of human amyloid peptide protein

<400> 2
Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys  
  1               5                  10                  15    

Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys Gly Ala Ile Ile  
             20                  25                  30        

Gly Leu Met Val Gly Gly Val Val Ile Ala                          
         35                  40        


<210> 3
<211> 28
<212> PRT
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Amino acids
      1-28 of human amyloid peptide protein

<400> 3
Asp Ala Glu Phe Arg His Asp Ser Gly Tyr Glu Val His His Gln Lys  
  1               5                  10                  15    

Leu Val Phe Phe Ala Glu Asp Val Gly Ser Asn Lys                  
             20                  25            


<210> 4
<211> 39
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 4
gtttaaacgc ggccgccgta tttataggtt tttttatta                        39    


<210> 5
<211> 36
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 5
ttttattact agtcccgggg atctgtgatt gtaaat                           36    


<210> 6
<211> 36
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 6
aagagctcgc tagcgtattt ataggttttt ttatta                           36    


<210> 7
<211> 38
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 7
acaatcacag atccccggga ctagtaataa aacctaga                         38    


<210> 8
<211> 18
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 8
gtttaaacgc ggccgccg                                               18    


<210> 9
<211> 17
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 9
aagagctcgc tagcgta                                                17    


<210> 10
<211> 17
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 10
aacagagatc gatctgt                                                17    


<210> 11
<211> 32
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:Primer

<400> 11
cataaaaatt aaaaattaaa atataattaa gg                               32    


